Avidity Partners Management as of March 31, 2024
Portfolio Holdings for Avidity Partners Management
Avidity Partners Management holds 87 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fusion Pharmaceuticals (FUSN) | 4.8 | $139M | 6.5M | 21.32 | |
| Boston Scientific Corporation (BSX) | 4.6 | $134M | 2.0M | 68.49 | |
| Arvinas Ord (ARVN) | 4.2 | $123M | 3.0M | 41.28 | |
| Intuitive Surgical Com New (ISRG) | 3.1 | $90M | 226k | 399.09 | |
| Intra Cellular Therapies (ITCI) | 2.9 | $83M | 1.2M | 69.20 | |
| Dianthus Therapeutics (DNTH) | 2.8 | $82M | 2.7M | 30.00 | |
| Acadia Healthcare (ACHC) | 2.7 | $80M | 1.0M | 79.22 | |
| Neurocrine Biosciences (NBIX) | 2.5 | $74M | 537k | 137.92 | |
| Natera (NTRA) | 2.5 | $74M | 803k | 91.46 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.4 | $70M | 584k | 120.42 | |
| Avantor (AVTR) | 2.4 | $69M | 2.7M | 25.57 | |
| Cigna Corp (CI) | 2.3 | $67M | 185k | 363.19 | |
| Merck & Co (MRK) | 2.3 | $66M | 502k | 131.95 | |
| Regeneron Pharmaceuticals (REGN) | 2.3 | $65M | 68k | 962.49 | |
| Cg Oncology | 2.2 | $64M | 1.5M | 43.90 | |
| Illumina (ILMN) | 2.2 | $64M | 464k | 137.32 | |
| Tenet Healthcare Corp Com New (THC) | 2.2 | $63M | 601k | 105.11 | |
| Align Technology (ALGN) | 2.1 | $62M | 189k | 327.92 | |
| Syndax Pharmaceuticals (SNDX) | 2.0 | $57M | 2.4M | 23.80 | |
| Eli Lilly & Co. (LLY) | 1.9 | $55M | 70k | 777.96 | |
| Cytokinetics Com New (CYTK) | 1.8 | $54M | 766k | 70.11 | |
| United Therapeutics Corporation (UTHR) | 1.7 | $50M | 217k | 229.72 | |
| Alpine Immune Sciences (ALPN) | 1.6 | $47M | 1.2M | 39.64 | |
| Ultragenyx Pharmaceutical (RARE) | 1.5 | $44M | 934k | 46.69 | |
| CVS Caremark Corporation (CVS) | 1.5 | $44M | 545k | 79.76 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.5 | $44M | 1.0M | 42.86 | |
| Surgery Partners (SGRY) | 1.5 | $43M | 1.4M | 29.83 | |
| Abbvie (ABBV) | 1.4 | $41M | 227k | 182.10 | |
| Blueprint Medicines (BPMC) | 1.4 | $40M | 426k | 94.86 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.3 | $38M | 668k | 56.09 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $36M | 243k | 149.45 | |
| Danaher Corporation (DHR) | 1.2 | $36M | 144k | 249.72 | |
| Ideaya Biosciences (IDYA) | 1.2 | $35M | 800k | 43.88 | |
| Axsome Therapeutics (AXSM) | 1.2 | $34M | 431k | 79.80 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $31M | 710k | 43.05 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.0 | $30M | 480k | 62.24 | |
| Caribou Biosciences (CRBU) | 1.0 | $30M | 5.8M | 5.14 | |
| Mirum Pharmaceuticals (MIRM) | 1.0 | $29M | 1.1M | 25.12 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $28M | 1.0M | 26.94 | |
| Regenxbio Inc equity us cm (RGNX) | 0.9 | $27M | 1.3M | 21.07 | |
| Apogee Therapeutics (APGE) | 0.9 | $26M | 385k | 66.45 | |
| Neumora Therapeutics (NMRA) | 0.9 | $25M | 1.8M | 13.75 | |
| Dex (DXCM) | 0.8 | $25M | 177k | 138.70 | |
| Neurogene (NGNE) | 0.8 | $24M | 465k | 50.90 | |
| Jasper Therapeutics Com New (JSPR) | 0.8 | $22M | 760k | 29.36 | |
| Immunome (IMNM) | 0.7 | $22M | 874k | 24.68 | |
| Thermo Fisher Scientific (TMO) | 0.7 | $21M | 37k | 581.21 | |
| Glaukos (GKOS) | 0.7 | $21M | 224k | 94.29 | |
| Revolution Medicines (RVMD) | 0.7 | $21M | 635k | 32.23 | |
| Vaxcyte (PCVX) | 0.7 | $19M | 284k | 68.31 | |
| Immunocore Hldgs Ads (IMCR) | 0.6 | $19M | 286k | 65.00 | |
| Phathom Pharmaceuticals (PHAT) | 0.6 | $18M | 1.7M | 10.62 | |
| McKesson Corporation (MCK) | 0.6 | $18M | 33k | 536.85 | |
| Vera Therapeutics Cl A (VERA) | 0.6 | $17M | 384k | 43.12 | |
| Immunovant (IMVT) | 0.6 | $16M | 505k | 32.31 | |
| Privia Health Group (PRVA) | 0.5 | $15M | 764k | 19.59 | |
| Janux Therapeutics (JANX) | 0.5 | $15M | 384k | 37.65 | |
| Cybin Ord (CYBN) | 0.5 | $14M | 35M | 0.41 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.5 | $14M | 361k | 38.82 | |
| Prime Medicine (PRME) | 0.5 | $14M | 2.0M | 7.00 | |
| Keros Therapeutics (KROS) | 0.5 | $14M | 210k | 66.20 | |
| Astria Therapeutics (ATXS) | 0.5 | $14M | 982k | 14.07 | |
| Ac Immune Sa SHS (ACIU) | 0.5 | $13M | 4.5M | 2.96 | |
| Karyopharm Therapeutics (KPTI) | 0.4 | $13M | 8.3M | 1.51 | |
| Immunic (IMUX) | 0.4 | $12M | 8.9M | 1.32 | |
| RadNet (RDNT) | 0.4 | $12M | 238k | 48.66 | |
| Establishment Labs Holdings Ord (ESTA) | 0.4 | $12M | 225k | 50.90 | |
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 0.4 | $11M | 475k | 23.65 | |
| ACADIA Pharmaceuticals (ACAD) | 0.4 | $11M | 589k | 18.49 | |
| Astrazeneca Sponsored Adr (AZN) | 0.4 | $11M | 160k | 67.75 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.3 | $9.0M | 1.7M | 5.35 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $5.6M | 130k | 43.35 | |
| Century Therapeutics (IPSC) | 0.2 | $5.1M | 1.2M | 4.18 | |
| Kyverna Therapeutics | 0.2 | $5.0M | 202k | 24.84 | |
| Emergent BioSolutions (EBS) | 0.2 | $4.8M | 1.9M | 2.53 | |
| Kezar Life Sciences (KZR) | 0.2 | $4.5M | 5.0M | 0.90 | |
| Biohaven (BHVN) | 0.1 | $4.1M | 75k | 54.69 | |
| An2 Therapeutics (ANTX) | 0.1 | $3.7M | 1.2M | 3.25 | |
| Ginkgo Bioworks Holdings Cl A Shs (DNA) | 0.1 | $3.5M | 3.0M | 1.16 | |
| X4 Pharmaceuticals (XFOR) | 0.1 | $3.4M | 2.4M | 1.39 | |
| Cogent Biosciences (COGT) | 0.1 | $3.0M | 446k | 6.72 | |
| Pacific Biosciences of California (PACB) | 0.1 | $2.5M | 675k | 3.75 | |
| Scynexis Com New (SCYX) | 0.1 | $2.1M | 1.4M | 1.47 | |
| Kodiak Sciences (KOD) | 0.1 | $1.6M | 300k | 5.26 | |
| Hyperfine Com Cl A (HYPR) | 0.0 | $1.2M | 1.2M | 1.00 | |
| Caremax Cl A New (CMAX) | 0.0 | $102k | 21k | 4.82 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $27k | 90k | 0.30 |
